We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tenet Healthcare
THC
$20.5B
| $11.1M | 0.21% |
+165,990
| New | +$10.3M |
|
127
Exelixis
EXEL
$13.3B
| $11M | 0.2% |
601,800
+3,492
| +0.6% | +$81.4K |
|
128
Affirm
AFRM
$23.9B
| $10.9M | 0.2% |
161,629
+2,061
| +1% | +$131K |
|
|
TBIO
129
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $10.9M | 0.2% |
+27,439
| New | +$9.7M |
|
|
OTLY
130
Oatly Group
OTLY
$465M
| $10.7M | 0.2% |
+21,828
| New | +$10.8M |
|
131
Relay Therapeutics
RLAY
$4.1B
| $10.6M | 0.2% |
288,557
+50,117
| +21% | +$1.65M |
|
|
TSP
132
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $10.3M | 0.19% |
+144,874
| New | +$6.23M |
|
|
HMCO
133
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $10.3M | 0.19% |
1,055,321
| – | – |
|
134
Chewy
CHWY
$9.25B
| $10M | 0.19% |
125,678
+12,974
| +12% | +$1M |
|
135
Arvinas
ARVN
$518M
| $9.88M | 0.18% |
128,250
| – | – |
|
|
SYNH
136
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $9.7M | 0.18% |
+108,438
| New | +$9.16M |
|
137
DaVita
DVA
$15.4B
| $9.55M | 0.18% |
+79,281
| New | +$9.38M |
|
138
Jabil
JBL
$33B
| $9.55M | 0.18% |
164,272
-121,796
| -43% | -$6.7M |
|
|
LENZ
139
LENZ Therapeutics
LENZ
$166M
| $9.52M | 0.18% |
+44,246
| New | +$7.71M |
|
140
Hydrofarm Holdings
HYFM
$2.57M
| $9.51M | 0.18% |
+16,084
| New | +$9.46M |
|
141
ICU Medical
ICUI
$4.21B
| $9.51M | 0.18% |
46,192
-32,283
| -41% | -$6.64M |
|
142
Planet Fitness
PLNT
$4.42B
| $9.37M | 0.17% |
124,475
+20,932
| +20% | +$1.67M |
|
143
UnitedHealth
UNH
$376B
| $9.22M | 0.17% |
23,014
+6,841
| +42% | +$2.73M |
|
144
ZIM Integrated Shipping Services
ZIM
$3.04B
| $9.2M | 0.17% |
204,803
+46,668
| +30% | +$1.8M |
|
145
Outset Medical
OM
$84.7M
| $9.17M | 0.17% |
12,229
+2,594
| +27% | +$1.98M |
|
146
Clear Channel Outdoor Holdings
CCO
$1.23B
| $8.96M | 0.17% |
+3,393,988
| New | +$8.14M |
|
147
International Flavors & Fragrances
IFF
$20.2B
| $8.77M | 0.16% |
58,679
+19,895
| +51% | +$2.86M |
|
148
AbCellera Biologics
ABCL
$1.74B
| $8.73M | 0.16% |
396,816
+141,914
| +56% | +$3.91M |
|
149
Agios Pharmaceuticals
AGIO
$1.79B
| $8.66M | 0.16% |
157,191
-666,906
| -81% | -$37.3M |
|
150
Icon
ICLR
$12.6B
| $8.55M | 0.16% |
+41,349
| New | +$8.92M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.